In a recent study published in RMD Open, the long-term safety profile of upadacitinib, a medication utilized in the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD),...
In a recent study published in RMD Open, the long-term safety profile of upadacitinib, a medication utilized in the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD),...
In a recent study published in...